Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat

References

• Achim CL, Masliah E, Heyes MP, Sarnacki PG, Hilty C, Baldwin M, Wiley CA (1996). Macrophage activation factors in the brains of AIDS patients. Journal of Neuro-AIDS 1: 1–16.
   PubMedGoogle Scholar
• Azad AA, Failla P. Lucantoni A, Bentley I, Mardon C, Wolfe A, Fuller K, Hewish D, Sengupta S. Sankovich S et al (1994). Large-scale production and character-ization of recombinant human immunodeficiency virus type1 Nef. I Gen Virol 75: 651–655.
   Google Scholar
• Brana C, Biggs TE, Barton CFI, Sundstrom LE and Mann DA (1999). A soluble factor produced by macrophages mediates the neurotoxic effects of HIV-I Tat in vitro. Aids 13: 1443–1452.
   Google Scholar
• Chao CC, Hu S, Gekker G, Lokensgard JR, Heyes MP, Peterson PK (2000). U50,488 protection against FIEV-1-related neurotoxicity: involvement of quinolinic acid suppression. Neuropharmacology 39: 150–160.
   PubMed Web of Science ®Google Scholar
• De SK, Marsh JW (1994). HIV-I Nef inhibits a common activation pathway in NTH-3T3 cells. I Biol Chem 269: 6656–6660.
   Google Scholar
• Gelbard HA, Nottet HS, Swindells S. Jett M, Dzenko KA, Genis P, White R, Wang L, Choi YB, Zhang D et al (1994). Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. I Virol 68: 4628–4635.
   PubMed Web of Science ®Google Scholar
• Glass JD, Fedor H, Wesselingh SL, McArthur IC (1995). Immunocytochemical quantitation of human immuno-deficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755–762
   PubMed Web of Science ®Google Scholar
• Guillemin GI, Kerr SJ, Smythe GA, Armati Pj, Brew BJ (1999). Kynurenine pathway metabolism in human astrocytes. Adv Exp Med Biol 467: 125–131.
   PubMed Web of Science ®Google Scholar
• Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP (1996). Human microglia convert 1-tryptophan into the neurotoxin quinolinic acid. Biochem J 320: 595–597.
   PubMed Web of Science ®Google Scholar
• Heyes MP, Brew B, Martin A, Markey SP, Price RW, Bhalla RB, Salazar A (1991a). Cerebrospinal fluid quinolinic acid concentrations are increased in ac-quired immune deficiency syndrome. Adv Exp Med Biol 294: 687–690.
   PubMedGoogle Scholar
• Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp I, et al (1991b). Quinolinic acid in cerebrospinal fluid and serum in HIV-I infection: relationship to clinical and neurological status. Ann Neurol 29: 202–209.
   PubMed Web of Science ®Google Scholar
• Kerr SJ, Armati PI., Brew BJ (1995). Neurocytotoxity of quinolinic acid in human brain cultures [see com-ments]. I Neurovirol 1: 375–380.
   PubMed Web of Science ®Google Scholar
• Kerr SJ, Armati PI., Guillemin GI, Brew BJ (1998). Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. Aids 12: 355–363.
   PubMed Web of Science ®Google Scholar
• Kerr SJ, Armati PI., Pemberton LA, Smythe G, Tattam B, Brew BI (1997). Kynurenine pathway inhibition reduces neurotoxicity of HIV-I-infected macrophages. Neurology 49: 1671–1681.
   PubMed Web of Science ®Google Scholar
• Magnuson DS, Knudsen BE, Geiger JD, Brownstone RM, Nath A (1995). Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory ami-no acid receptors and causes neurotoxicity. Ann Neurol 37: 373–380.
   PubMed Web of Science ®Google Scholar
• Masliah E, Heaton RK, Marcotte TD, Ellis RI, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson IH, Grant I (1997). Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. FINRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 42: 963–972.
   Google Scholar
• Nath A, Geiger I. (1998). Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog Neurobiol 54: 19–33.
   PubMed Web of Science ®Google Scholar
• Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD (2000). Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine., Ann Neurol 47: 186–194.
   Google Scholar
• Pemberton LA, Kerr SJ, Brew BI (1997). HIV-I gp120 does not induce Quinolinic acid production by macrophages [letter]. J Neurovirol 3: 86–87.
   Web of Science ®Google Scholar
• Pemberton LA, Kerr SJ, Smythe G, Brew III (1997). Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha. I Inter-feron Cytokine Res 17: 589–595.
   Google Scholar
• Perry SW, Hamilton JA, Tjoelker LW, Dbaibo G, Dzenko KA, Epstein LG, Hannun Y, Whittaker IS, Dewhurst S. Gelbard HA (1998). Platelet-activating factor receptor activation. An initiator step in HIV-I neuropathogen-esis. I Biol Chem 273: 17660–17664.
   Google Scholar
• Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Raininko R, Haapasalo H, Krohn K (1995). Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. Aids 9: 1001–1008.
   PubMed Web of Science ®Google Scholar
• Saito Y, Sharer LR, Epstein LG, Michaels j, Mintz M, Louder M, Golding K, Cvetkovich TA, Blumberg BM (1994). Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44: 474–481.
   PubMed Web of Science ®Google Scholar
• Schifitto G, Sacktor N, Marder K, McDermott MP, McArthur IC, Kieburtz K, Small S, Epstein LG (1999). Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium. Neurology 53: 391–396.
   Google Scholar
• Stone TW (1993). Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45: 309–379.
   PubMed Web of Science ®Google Scholar
• Werner T, Ferroni S. Saermark T, Brack-Werner R, Banati RB, Mager R, Steinaa L, Kreutzberg GW, Erfle V (1991). HIV-I Nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels. Aids 5: 1301–1308.
   Google Scholar
• Whetsell WO Jr, Schwarcz R (1989). Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett 97: 271–275.
   Google Scholar
• Yuan W, Collado-Hidalgo A, Yufit T, Taylor M, Varga J (1998). Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygen-ase and tryptophanyl-tRNA synthetase gene expres-sion. I Cell Physiol 177: 174–186.
   PubMed Web of Science ®Google Scholar